Real World Registry for Use of the Ion Endoluminal System
← catalyst calendarNCT06004440 · readout ≤ 377 d
Sponsored by Intuitive Surgical (industry) · ISRG — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
1,301actual
Sites
16
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-09-21 | actual | When the study began enrolling |
| Primary completion | Aug 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Aug 2028 | estimated | The whole study's end, after follow-up |
| First posted | 2023-08-22 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-04-24 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Lung Cancer
- Multiple Pulmonary Nodules
- Lung Neoplasms
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Neoplasms by Site
- Neoplasms
- Lung Diseases
- Respiratory Tract Diseases
Intervention
- Device: Ion Endoluminal System
Primary outcome
what the primary-completion date above is the date OFPrimary Endpoint to Assess Diagnostic Yield
measured Intra-procedure through the 24 month follow up period
Permalink · ISRG's whole pipeline · Catalyst calendar · Every registered study · What changed